Qualified institutional researchers seeking to buy CJC-1295 online for laboratory applications require verifiable purity, rigorous lot traceability, and comprehensive analytical documentation. PX1 Research supplies USA-manufactured CJC-1295 synthesized under strict ISO 17025 standards for preclinical in vitro and animal research models.
Qualified institutional researchers seeking to buy CJC-1295 online for laboratory applications require verifiable purity, rigorous lot traceability, and comprehensive analytical documentation. PX1 Research supplies USA-manufactured CJC-1295 synthesized under strict ISO 17025 standards for preclinical in vitro and animal research models.
When sourcing CJC-1295 online for laboratory research, investigators must ensure the compound is verified via reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry (MS) to guarantee ≥98% purity. PX1 Research provides USA-manufactured, endotoxin-tested CJC-1295 accompanied by lot-specific Certificates of Analysis for strict research compliance.
Sourcing high-integrity research compounds online requires transparent verification of chemical identity, sequence accuracy, and freedom from synthesis side-products. For biomedical laboratories investigating the somatotropic axis, accessing reagents with complete analytical transparency is essential to maintaining experimental reproducibility across cell culture and animal studies. PX1 Research fulfills these requirements by manufacturing peptides in US-based, GMP-compliant facilities and subjecting every lot to independent analytical validation.
CJC-1295 is a synthetic 29-amino-acid peptide analog of growth hormone-releasing hormone (GHRH). Modified at key residue positions (specifically positions 2, 8, 15, and 27) relative to native GHRH(1-29), the molecule is optimized to resist rapid enzymatic cleavage by dipeptidyl peptidase-IV (DPP-IV). This structural refinement extends the biological half-life of the compound while preserving selective binding affinity for the growth hormone-releasing hormone receptor (GHRH-R) on anterior pituitary somatotrophs.
Upon receptor binding, CJC-1295 stimulates the G-protein coupled receptor signaling cascade, activating adenylate cyclase and increasing intracellular cyclic adenosine monophosphate (cAMP) levels. This downstream cascade triggers the synthesis and pulsatile secretion of endogenous growth hormone (GH), which subsequently induces hepatic production of insulin-like growth factor 1 (IGF-1). Studied primarily as a long-acting GHRH analog, CJC-1295 sustains GH and downstream IGF-1 levels, providing researchers with a reliable molecular tool to evaluate tissue repair research, cellular differentiation, and protein translation dynamics in preclinical models.
In vitro data and rodent models demonstrate that CJC-1295 maintains sustained activation of the somatotropic axis without ablating the physiological pulsatility of growth hormone release. Unlike direct recombinant GH administration—which can cause non-physiologic plasma spikes and receptor downregulation—GHRH analogs like CJC-1295 leverage endogenous pituitary reserves, preserving physiological feedback loops governed by somatostatin.
Preclinical studies suggest that extended elevation of serum GH and IGF-1 via CJC-1295 enhances nitrogen retention, accelerates extracellular matrix remodeling, and modulates lipid oxidation parameters in experimental models. Investigators evaluating musculoskeletal regeneration, satellite cell activation, and connective tissue synthesis frequently utilize CJC-1295 to delineate the specific pathways through which sustained IGF-1 transcription influences cellular repair and metabolic homeostasis.
When reviewing options to buy CJC-1295 online, researchers must distinguish between two primary molecular variants: CJC-1295 with Drug Affinity Complex (DAC) and CJC-1295 without DAC (commonly designated as Modified GRF 1-29). The DAC modification involves the addition of a maleimide moiety attached to the lysine residue at the C-terminus via a linker.
In vivo assays indicate that the DAC moiety allows the peptide to covalently bind to circulating serum albumin following administration. This bioconjugation shields the compound from renal clearance and enzymatic degradation, extending its biological half-life from approximately 30 minutes to over 6–8 days in mammalian models. Conversely, CJC-1295 No DAC lacks this bioconjugate linker, resulting in a rapid pharmacokinetic profile ideal for acute, short-duration stimulation protocols in laboratory settings. Institutional buyers can explore both formulations within our research peptides catalog to suit specific experimental design requirements.
To select the optimal growth hormone axis modulator, laboratories frequently compare CJC-1295 alongside other secretagogues within the same peptide class. Understanding these structural and functional differences allows researchers to tailor target receptor stimulation precisely.
Preclinical literature demonstrates distinct pharmacodynamic profiles among these agents. For instance, Sermorelin represents the truncated native sequence (GHRH 1-29) with a short biological half-life, requiring frequent administration in model systems. In contrast, Tesamorelin features a hexenoyl moiety attached to the N-terminal amino acid sequence of GHRH, specifically evaluated in preclinical models for its potent lipolytic activity and metabolic selectivity. Furthermore, pairing CJC-1295 with a growth hormone secretagogue receptor (GHSR) agonist such as Ipamorelin yields a synergistic elevation of GH release by simultaneously activating dual signaling pathways (GHRH-R and GHSR) without significantly raising cortisol or prolactin concentrations.
The scientific validity of any preclinical study depends fundamentally on chemical purity. Substandard reagents containing truncated peptide sequences, residual synthesis reagents, or high endotoxin burdens introduce uncontrolled variables that invalidate assay outcomes and harm cultured cell lines.
At PX1 Research, every batch of CJC-1295 undergoes multi-tiered analytical testing in an ISO 17025 accredited laboratory facility:
• Reverse-Phase HPLC (RP-HPLC): Establishes chromatographic purity, ensuring the target peptide accounts for ≥98.0% of the total integrated peak area. • Electrospray Ionization Mass Spectrometry (ESI-MS): Confirms exact molecular weight and amino acid sequence fidelity against theoretical values. • Chromogenic LAL Endotoxin Testing: Verifies endotoxin levels remain below strict institutional thresholds (<0.05 EU/mg), ensuring compatibility with sensitive cell cultures and primary cell assays. • Residual Solvent & Heavy Metal Analysis: Ensures complete removal of trifluoroacetic acid (TFA) salts and synthesis reagents.
Proper handling and reconstitution protocols are vital to maintain the structural integrity of CJC-1295 once received in the laboratory. Lyophilized peptide cakes should be visually inspected upon delivery to verify a uniform, white to off-white solid powder before processing.
Reconstitution should be conducted under sterile laminar flow hoods using sterile bacteriostatic water (containing 0.9% benzyl alcohol) or sterile endotoxin-free water depending on downstream assay parameters. The solvent should be directed down the glass wall of the vial rather than sprayed directly onto the lyophilized cake to prevent mechanical shear stress. Gentle swirling or slow rotation of the vial is recommended; vortexing must be strictly avoided as agitation can disrupt secondary peptide structure and cause aggregation.
Lyophilized CJC-1295 demonstrates high thermal stability when stored under controlled environment conditions prior to reconstitution. Unopened vials should be preserved at -20°C for short-to-medium term storage, or at -80°C for long-term biobanking, desiccated away from ambient light and moisture.
Following reconstitution, liquid aliquots should be used immediately or stored at 2°C to 8°C for short-term experimental series (typically up to 14–21 days when prepared with bacteriostatic water). For longer storage of reconstituted solutions, working aliquots should be frozen at -20°C or -80°C to minimize repeated freeze-thaw cycles, which degrade peptide bonds over time. Detailed handling guidelines and documentation can be reviewed through our central research hub.
PX1 Research is dedicated to supporting academic, biotechnology, and institutional research facilities with uncompromising reagent purity and dependable supply chain logistics. All products are manufactured in the United States, shipped directly from our primary distribution facilities in California and Arizona, and backed by comprehensive documentation.
Orders placed Monday through Friday ship same-day, ensuring minimal transit exposure and reliable project timelines. Principal investigators and procurement directors managing high-volume studies can request custom batch sizes, specific salt-form adjustments, or dedicated analytical panels through our specialized wholesale account program.
What is the primary biological mechanism of CJC-1295 in laboratory research?
CJC-1295 functions as a synthetic analog of growth hormone-releasing hormone (GHRH). It selectively binds to the GHRH receptor on anterior pituitary somatotrophs, stimulating adenylate cyclase and cAMP signaling to promote sustained synthesis and secretion of endogenous growth hormone (GH) and downstream IGF-1.
How does CJC-1295 with DAC differ from CJC-1295 without DAC?
CJC-1295 with Drug Affinity Complex (DAC) includes a maleimide-containing linker that covalently binds to circulating serum albumin, extending its biological half-life to several days in animal models. CJC-1295 No DAC (Mod GRF 1-29) lacks this linker, resulting in a much shorter plasma half-life (~30 minutes) suitable for acute baseline studies.
How can researchers verify the purity when buying CJC-1295 online?
High-purity CJC-1295 should be supported by lot-specific Certificates of Analysis (COA) displaying Reverse-Phase HPLC chromatograms showing ≥98% purity, Mass Spectrometry confirming exact molecular mass, and chromogenic LAL assays confirming low endotoxin levels.
What solvent is recommended for reconstituting CJC-1295 for laboratory work?
Lyophilized CJC-1295 is typically reconstituted using sterile bacteriostatic water (0.9% benzyl alcohol) for multiple-dose experimental protocols, or sterile endotoxin-free water for sensitive cell culture assays where preservatives might interfere with cellular viability.
What are the recommended storage temperatures for lyophilized CJC-1295?
Lyophilized CJC-1295 should be stored at -20°C or -80°C in a desiccated freezer away from light. Under these conditions, the unhandled peptide maintains chemical stability for extended periods.
Why is endotoxin testing critical for research-grade peptides?
Endotoxins (lipopolysaccharides) from bacterial synthesis can cause inflammatory responses, cell toxicity, or receptor desensitization in cell culture and animal models, confounding experimental findings. PX1 Research tests all lots to ensure endotoxin levels remain below strict laboratory limits (<0.05 EU/mg).
Can CJC-1295 be combined with other peptides in preclinical studies?
Yes, in preclinical literature, CJC-1295 is frequently evaluated alongside growth hormone secretagogue receptor agonists like Ipamorelin to investigate dual-receptor synergistic secretion of growth hormone.
Is CJC-1295 supplied by PX1 Research approved for human consumption or therapeutic use?
No. All products supplied by PX1 Research, including CJC-1295, are synthesized strictly for laboratory research, in vitro assays, and preclinical animal studies. They are not for human or animal diagnostic, therapeutic, or clinical application.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.